BIOMARKERS OF THE BLOOD AND CEREBROSPINAL FLUID IN THE DIAGNOSIS AND PROGNOSIS OF NON-TRAUMATIC INTRACEREBRAL HEMORRHAGE
https://doi.org/10.51523/2708-6011.2016-13-1-1
Abstract
The article presents the most prospective biomarkers of intracerebral hemorrhage (ICH) of the blood and cerebrospinal fluid (CSF) and describes their potential role in the diagnosis, treatment, and prognosis of non-traumatic ICH.
References
1. Henley, S. Biomarkers for neurodegenerative diseases / S. Henley, G. Bates, S. Tabrizi // Curr. Opin. Neurol. - 2005. - Vol. 18. - P. 698-705.
2. Tuntiyatorn, L. Identification of stroke mimics among clinically diagnosed acute strokes // L. Tuntiyatorn, P. Saksornchai, S. Tunlayade-chanont // J. Med. Assoс. Thai. - 2013. - Vol. 96. - P.1191-1198.
3. Bettermann, K. Biomarkers for stroke: in search of fingerprints / K. Bettermann // J. Stroke Cerebrovasc. Dis. - 2011. - Vol. 20. - P. 173-176.
4. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke / F. Dvorak [et al.] // Cerebrovasc. Dis. - 2009. - Vol. 27. - P. 173-176.
5. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway / J. Montaner [et al.] // Proteomics. - 2009. - Vol. 75. - P. 4785-4765.
6. ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke / L. Allard [et al.] // Proteomics. - 2009. - Vol. 4. - P. 2242-2251.
7. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage / S. Moritz [et al.]. // J. Neurosurg. Anesthesiol. - 2010. - Vol. 22. - P. 21-23.
8. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern / A. Petzold [et al.] // Brain Res. Bull. - 2003. - Vol. 61(3). - P. 281-285.
9. Plasma S100B level after acute spontaneous intracerebral hemorrhage / P. Delgado [et al.] // Stroke. - 2006. - Vol. 37(11). - P. 2837-2839
10. Identification of Novel Biomarkers of Brain Damage in Patients with Hemorrhagic Stroke by Integrating Bioinformatics and Mass Spectrometry-Based Proteomics / E. Martínez-Morillo [et al.] // J. Proteome Res. - 2014. - Vol. 14. - P. 969-981.
11. Axonal pathology in subarachnoid and intracerebral hemorrhage / A. Petzold [et al.] // J. Neurotrauma. - 2005. - Vol. 22(3). - P. 407-411.
12. Plasma beta-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke / M. Hernandez-Guillamon [et al.] // Neurodegener. Dis. - 2012. - Vol. 10. - P. 320-323.
13. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage / S. Abilleira [et al.] // J. Neurosurg. - 2003. - Vol. 99. - P. 65-70.
14. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage / Y. Silva [et al.] // Stroke. - 2005. - Vol. 36. - P. 86-92.
15. Sviri, G. Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury / G. Sviri, J. Soustiel, M. Zaaroor // Acta Neurochir (Wein). - 2006. - Vol. 148. - P. 529-533.
16. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke / M. Hernandez-Guillamon [et al.] // Cerebrovasc. Dis. - 2012. - Vol. 33. - P. 55-63.
17. Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage / P. Delgado [et al.] // Stroke. - 2008. - Vol. 39. - P. 1730-1734.
18. S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage. M. James [et al.] // Biomarkers. - 2009. - Vol. 14. - P. 388-394.
19. Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study / S. Lee [et al.] // Diabetologia. - 2010. - Vol. 53. - P. 429-434.
20. Molecular signatures of brain injury after intracerebral hemorrhage / J. Castillo [et al.] // Neurology. - 2002. - Vol. 58. - P. 624-629.
21. Molecular biomarker of inflammatory response is associated with rebleeding in spontaneous intracerebral hemorrhage / K. Wang [et al.] // Eur. Neurol. - 2011. - Vol. 66. - P. 322-327.
22. C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score / M. Di Napoli [et al.] // Eur. Neurol. - 2012. - Vol. 5. - P. 52-57.
23. Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage / D. Rodriguez-Luna [et al.] // Stroke. - 2011. - Vol. 42. - P. 2447-2452.
24. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage / T. Steiner [et al.] // Int. J. Stroke. - 2014. - Vol. 9. - P. 840-855.
25. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association / L. B. Morgenstern [et al.] // Stroke. - 2010. - Vol. 41. - P. 2108-2129.
Review
For citations:
Timenova S.V. BIOMARKERS OF THE BLOOD AND CEREBROSPINAL FLUID IN THE DIAGNOSIS AND PROGNOSIS OF NON-TRAUMATIC INTRACEREBRAL HEMORRHAGE. Health and Ecology Issues. 2016;(1):4-7. (In Russ.) https://doi.org/10.51523/2708-6011.2016-13-1-1
Views: 334
Email this article 